Yüklüyor......
Risk of Diabetes among Patients Receiving Primary Androgen Deprivation Therapy for Clinically Localized Prostate Cancer
PURPOSE: Androgen deprivation therapy may increase diabetes risk. As the benefits of primary androgen deprivation therapy for localized prostate cancer are controversial, and most prostate cancer survivors are of advanced age with comorbidities, it is important to determine if primary androgen depri...
Kaydedildi:
| Yayımlandı: | J Urol |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4543371/ https://ncbi.nlm.nih.gov/pubmed/25524243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2014.12.027 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|